Department of Ophthalmology, Rigshospitalet-Glostrup, Glostrup, Denmark.
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
JAMA Ophthalmol. 2022 Jul 1;140(7):667-673. doi: 10.1001/jamaophthalmol.2022.1002.
Thyroid eye disease (TED) is a serious condition that can cause proptosis and strabismus and, in rare cases, lead to blindness. Incidence data for TED and strabismus and surgical interventions after TED are sparce.
To investigate the nationwide incidence of TED, strabismus, and surgical interventions associated with TED.
DESIGN, SETTING, AND PARTICIPANTS: A Danish nationwide registry-based cohort study between 2000, which marks the beginning of uniform coding for the decompression surgery nationwide, and 2018. The cohort consisted of a mean 4.3 million people aged 18 to 100 years with no prior TED diagnosis each year. Total observation time was 8.22 × 107 person-years (women, 4.18 × 107 person-years; men, 4.04 × 107 person-years).
The annual numeric and age-standardized incidence of hospital-treated TED and cumulative incidence of strabismus, strabismus surgery, and orbital decompression surgery in patients with TED. The incidence was stratified by sex, thyroid diagnosis, and age.
A total of 4106 incident diagnoses of TED were identified during 19 years among 3344 women (81.4%) and 762 men (18.6%). The mean numeric annual nationwide incidence rate of TED was 5.0 per 100 000 person-years overall, 8.0 per 100 000 person-years in women, and 1.9 per 100 000 person-years in men, resulting in a 4:1 ratio of women to men with TED. The age-standardized incidence was similar. The mean (SD) age at onset was 51.3 (14.5) years. At the time of TED diagnosis, 611 patients (14.9%) were euthyroid, 477 (11.6%) were hypothyroid, and 3018 (73.5%) were hyperthyroid. In patients with TED who were euthyroid, the 4-year cumulative incidence was 41% for antithyroid medication and 13% for L-thyroxine. In patients with TED, the 4-year cumulative incidence for strabismus was 10%. The 4-year cumulative incidence of surgical interventions after TED was 8% for strabismus surgery and 5% for orbital decompression. At 4 years, strabismus surgery was more common in men (13.3%; 95% CI, 10.75-15.86) than in women (7.2%; 95% CI, 6.24-8.08), and the absolute difference was 6.1% (95% CI, 3.42-8.14; P < .001).
This study in Denmark provides nationwide empirical incidence of TED and strabismus and surgical interventions after TED that required inpatient or outpatient hospital treatment, and might be used for patient information and health care planning.
甲状腺眼病(TED)是一种严重的疾病,可导致眼球突出和斜视,在极少数情况下还会导致失明。TED 和斜视的发病率数据以及 TED 后的手术干预措施非常有限。
调查丹麦全国 TED、斜视和与 TED 相关的手术干预措施的发病率。
设计、地点和参与者:这是一项基于丹麦全国登记的队列研究,研究时间为 2000 年至 2018 年,这一年标志着全国范围内减压手术的统一编码开始。该队列由每年平均 430 万 18 至 100 岁、无 TED 既往诊断的人群组成。总观察时间为 8.22×107 人年(女性为 4.18×107 人年,男性为 4.04×107 人年)。
在 19 年期间,共确定了 4106 例 TED 新发病例,涉及 3344 名女性(81.4%)和 762 名男性(18.6%)。全国范围内 TED 的平均年度数值发病率为 5.0/100000 人年,女性为 8.0/100000 人年,男性为 1.9/100000 人年,TED 女性与男性的比例为 4:1。发病率标准化后相似。发病的平均(SD)年龄为 51.3(14.5)岁。在 TED 诊断时,611 名患者(14.9%)甲状腺功能正常,477 名(11.6%)甲状腺功能减退,3018 名(73.5%)甲状腺功能亢进。TED 患者中甲状腺功能正常者,抗甲状腺药物的 4 年累积发病率为 41%,L-甲状腺素为 13%。TED 患者 4 年斜视累积发病率为 10%。TED 后的手术干预 4 年累积发病率为斜视手术 8%,眼眶减压术 5%。4 年内,男性斜视手术(13.3%;95%CI,10.75-15.86)比女性更常见(7.2%;95%CI,6.24-8.08),绝对差异为 6.1%(95%CI,3.42-8.14;P<.001)。
本研究在丹麦提供了 TED 和斜视的全国性经验发病率以及需要住院或门诊治疗的 TED 后手术干预措施,可用于患者信息和医疗保健规划。